Good- now we need public acknowledgement from AMDL/Radient/PDx regarding their plans to move forward with selling the colorectal cancer test to hospitals, clinical labs, clinics, and other healthcare organizations throughout the USA.
It appears all specifics are on hold until reverse merger is announced?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.